Andrea Schlegel, MD, MBA
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Andrea Schlegel, MD, MBA
Dr. Andrea Schlegel is an academic transplant surgeon at the Cleveland Clinic specialized in liver transplantation and hepato-biliary surgery. Her treatment philosophy is focused on a patient-centric and shared-decision making approach while incorporating the most recent innovative treatment concepts and technologies as she helps patients through their liver transplant journey.
Her research interests include both, experimental and clinical research in abdominal surgery with a focus on organ preservation to improve the safe utilization of organs. She has a large experience in designing clinical trials, and she works closely with her colleagues from different specialties, both at Cleveland Clinic but also within her large international network in the field.
Outside of work, Dr. Schlegel likes to travel and explore the outdoors.
Education & Professional Highlights
Appointed
2023
Education & Fellowships
Graduate School - Roberty Kennedy Collge- University of Cumbria
Zurich,
Switzerland
2021
Fellowship - European Fellowship in Liver Transplant Surgery and Hepatobiliary and pancreatic surgery
Liver Transplantation and multiorgan procurement; Hepatobiliary and pancreatic surgery
Birmingham,
United Kingdom
2018
Residency - University Hospital Zurich
Department of Visceral Surgery and Transplantation
Zurich,
Switzerland
2014
Fellowship - Kantonsspital Münsterlingen
Anesthesia and Intensive Care
Münsterlingen,
Switzerland
2014
Fellowship - University Hospital Zurich
Research fellowship, transplant surgery and Hepatobiliary/pancreatic surgery
Zurich,
Switzerland
2012
Residency - Kantonales Spital Grabs
General, abdominal and trauma surgery
Grabs,
Switzerland
2009
Medical Education - Justus-von-Liebig University
Giessen,
Germany
2007
Internship - Kantonsspital Winterthur
Abdominal and General Surgery
Winterthur,
Switzerland
Additional Training
Professional Highlights
- Dr. Schlegel obtained her medical degree with Honors from the Justus-Liebig-University Giessen (Germany). She completed her research fellowship and residency at the University Hospital Zurich (Switzerland), where she also served as Chief Resident and Staff Surgeon with a focus on quality improvement and patient safety in abdominal surgery and transplantation. She went on to complete her Transplant Surgery and Hepato-Pancreatico-Biliary Surgery fellowship training at Queen Elizabeth University Hospital Birmingham (United Kingdom) and was awarded with a Staff position as Transplant Surgeon before moving to Italy (Careggi Hospital Florence and Milan Policlinico), where she achieved the “National Scientifica Qualification” as Full Professor (06/C1 - General Surgery).
- Since 2011 her research is focused on a broad range of topics including dynamic organ preservation in context of transplantation, the development of new markers to predict organ viability, and underlying mechanisms of ischemia and reperfusion injury triggered by mitochondrial injury and dysfunction.
- Dr. Schlegel serves as Associated Editor and Reviewer in more than 15 leading journals in the field of surgery and organ transplantation and has various international collaborations worldwide with an average number of 20 invited lectures and presentations per year.
- Dr. Schlegel is board certified in General Surgery (FMH), Transplant Surgery (EBSQ/UEMS) and Hepato-Pancreatico-Biliary Surgery (EBSQ/UEMS) and obtained a Master in Business Administration (MBA, specialized in International Healthcare Management) from the Robert Kennedy College and University of Cumbria (United Kingdom and Switzerland).Certifications
- General Surgery
- Transplant Surgery
- Hepato-Pancreatico-Biliary Surgery
Awards & Honors
- Dr. Schlegel received over 18 international and national awards in the field of organ transplantation and hepato-biliary surgery, both, as a trainee and mentor.
Innovations & Patents
Memberships
- Dr. Schlegel is a member of the American Society of Transplantation, the International Liver Transplantation Society (ILTS), the European Society for Organ Transplantation (ESOT) and the European Liver and Intestine Transplant Association and the Swiss Transplantation Society and Swiss Surgical Society.
Research & Publications
See publications for Andrea Schlegel, MD, MBA.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 6/2/2023, Dr. Schlegel has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
